[1] ROUSSEAU-MERCK M F, HUEBNER K, BERGER R, et al. Chromosomal localization of two human zinc finger protein genes, ZNF24 (KOX17) and ZNF29 (KOX26), to 18q12 and 17p13-p12, respectively[J]. Genomics,1991,9(1):154-161. doi:  10.1016/0888-7543(91)90233-5
[2] HAN Z G, ZHANG Q H, YE M, et al. Molecular cloning of six novel Krüppel-like zinc finger genes from hematopoietic cells and identification of a novel transregulatory domain KRNB[J]. J Biol Chem,1999,274(50):35741-35748. doi:  10.1074/jbc.274.50.35741
[3] LI J Z, CHEN X, YANG H, et al. The zinc finger transcription factor 191 is required for early embryonic development and cell proliferation[J]. Exp Cell Res,2006,312(20):3990-3998. doi:  10.1016/j.yexcr.2006.08.020
[4] KHALFALLAH O, FAUCON-BIGUET N, NARDELLI J, et al. Expression of the transcription factor Zfp191 during embryonic development in the mouse[J]. Gene Expr Patterns,2008,8(3):148-154. doi:  10.1016/j.gep.2007.11.002
[5] KHALFALLAH O, RAVASSARD P, LAGACHE C S, et al. Zinc finger protein 191 (ZNF191/Zfp191) is necessary to maintain neural cells as cycling progenitors[J]. Stem Cells,2009,27(7):1643-1653. doi:  10.1002/stem.88
[6] LV L, ZHANG J W, WANG P, et al. Zinc finger protein 191 deficiency attenuates vascular smooth muscle cell proliferation, migration, and intimal hyperplasia after endovascular arterial injury[J]. J Vasc Surg,2014,59(2):500-509. doi:  10.1016/j.jvs.2013.03.049
[7] JIA D, HUANG L, BISCHOFF J, et al. The endogenous zinc finger transcription factor, ZNF24, modulates the angiogenic potential of human microvascular endothelial cells[J]. FASEB J,2015,29(4):1371-1382. doi:  10.1096/fj.14-258947
[8] HUANG M T, HUANG X, JIANG B M, et al. linc00174-EZH2-ZNF24/runx1-VEGFA regulatory mechanism modulates post-burn wound healing[J]. Mol Ther Nucleic Acids,2020,21:824-836. doi:  10.1016/j.omtn.2020.07.010
[9] LI J Z, CHEN X, GONG X L, et al. A transcript profiling approach reveals the zinc finger transcription factor ZNF191 is a pleiotropic factor[J]. BMC Genomics,2009,10:241. doi:  10.1186/1471-2164-10-241
[10] SHI S L, LIU M M, YU L, et al. Assignment of a novel zinc finger gene ZNF191 to human chromosome 18Q12.1 by human/rodent somatic cell hybrid panel and fluorescent in situ hybridization[J]. Shi Yan Sheng Wu Xue Bao,1998,31(1):21-27.
[11] AURELLO P, MINERVINI A, PACE M, et al. The role of surgery in the treatment of metachronous liver metastasis from gastric cancer: a systematic review[J]. Anticancer Res,2022,42(1):25-33. doi:  10.21873/anticanres.15453
[12] SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2021,71(3):209-249. doi:  10.3322/caac.21660
[13] LI H X, LI Y, TIAN D M, et al. miR-940 is a new biomarker with tumor diagnostic and prognostic value[J]. Mol Ther Nucleic Acids,2021,25:53-66. doi:  10.1016/j.omtn.2021.05.003
[14] LIU X Y, GE X X, ZHANG Z, et al. microRNA-940 promotes tumor cell invasion and metastasis by downregulating ZNF24 in gastric cancer[J]. Oncotarget,2015,6(28):25418-25428. doi:  10.18632/oncotarget.4456
[15] WAGNER A D, GROTHE W, HAERTING J, et al. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data[J]. J Clin Oncol,2006,24(18):2903-2909. doi:  10.1200/JCO.2005.05.0245
[16] WEINSTEIN J N, COLLISSON E A, MILLS G B, et al. The Cancer Genome Atlas Pan-Cancer analysis project[J]. Nat Genet,2013,45(10):1113-1120. doi:  10.1038/ng.2764
[17] HOU L M, CHEN M S, YANG H W, et al. MiR-940 Inhibited Cell Growth and Migration in Triple-Negative Breast Cancer[J]. Medical science monitor:international medical journal of experimental and clinical research,2016,22:3666-3672.
[18] WANG Z P, ZHU S, ZHAO J G, et al. The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first-line therapy for patients with metastatic castration-resistant prostate cancer[J]. Prostate,2021,81(15):1191-1201. doi:  10.1002/pros.24215
[19] SAVAGNER P. Epithelial-mesenchymal transitions: from cell plasticity to concept elasticity[J]. Curr Top Dev Biol,2015,112:273-300.
[20] DAS V, Bhattacharya S, Chikkaputtaiah C, et al. The basics of epithelial-mesenchymal transition(EMT): a study from a structure, dynamics, and functional perspective[J]. J Cell Physiol,2019:2019Feb5.
[21] ODERO-MARAH V, HAWSAWI O, HENDERSON V, et al. Epithelial-mesenchymal transition (EMT) and prostate cancer[J]. Adv Exp Med Biol,2018,1095:101-110.
[22] YAO D B, DAI C L, PENG S L. Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation[J]. Mol Cancer Res,2011,9(12):1608-1620. doi:  10.1158/1541-7786.MCR-10-0568
[23] WANG X H, LING M T, GUAN X Y, et al. Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells[J]. Oncogene,2004,23(2):474-482. doi:  10.1038/sj.onc.1207128
[24] HUANG X J, LIU N X, XIONG X. ZNF24 is upregulated in prostate cancer and facilitates the epithelial-to-mesenchymal transition through the regulation of Twist1[J]. Oncol Lett,2020,19(5):3593-3601.
[25] FERLAY J, COLOMBET M, SOERJOMATARAM I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods[J]. Int J Cancer,2019,144(8):1941-1953. doi:  10.1002/ijc.31937
[26] ALQAHTANI A, KHAN Z, ALLOGHBI A, et al. Hepatocellular carcinoma: molecular mechanisms and targeted therapies[J]. Medicina (Kaunas),2019,55(9):526. doi:  10.3390/medicina55090526
[27] LACHENMAYER A, ALSINET C, SAVIC R, et al. Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib[J]. Clin Cancer Res,2012,18(18):4997-5007. doi:  10.1158/1078-0432.CCR-11-2322
[28] LIU G, JIANG S, WANG C, et al. Zinc finger transcription factor 191, directly binding to β-catenin promoter, promotes cell proliferation of hepatocellular carcinoma[J]. Hepatology,2012,55(6):1830-1839. doi:  10.1002/hep.25564
[29] LIU Y F, WU D, CHENG H H, et al. Wnt8B, transcriptionally regulated by ZNF191, promotes cell proliferation of hepatocellular carcinoma via Wnt signaling[J]. Cancer Sci,2021,112(2):629-640. doi:  10.1111/cas.14738
[30] WU D, LIU G, LIU Y, et al. Zinc finger protein 191 inhibits hepatocellular carcinoma metastasis through discs large 1-mediated yes-associated protein inactivation[J]. Hepatology (Baltimore, Md.),2016,64(4):1148-1162. doi:  10.1002/hep.28708
[31] SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2019[J]. CA A Cancer J Clin,2019,69(1):7-34. doi:  10.3322/caac.21551
[32] MIRANDA-FILHO A, LORTET-TIEULENT J, BRAY F, et al. Thyroid cancer incidence trends by histology in 25 countries: a population-based study[J]. Lancet Diabetes Endocrinol,2021,9(4):225-234. doi:  10.1016/S2213-8587(21)00027-9
[33] PRETE A, BORGES DE SOUZA P, CENSI S, et al. Update on fundamental mechanisms of thyroid cancer[J]. Front Endocrinol (Lausanne),2020,11:102. doi:  10.3389/fendo.2020.00102
[34] XIONG J, JIANG P P, ZHONG L, et al. The novel tumor suppressor gene ZNF24 induces THCA cells senescence by regulating Wnt signaling pathway, resulting in inhibition of THCA tumorigenesis and invasion[J]. Front Oncol,2021,11:646511. doi:  10.3389/fonc.2021.646511
[35] YOUN H J, HAN W. A review of the epidemiology of breast cancer in Asia: focus on risk factors[J]. Asian Pac J Cancer Prev,2020,21(4):867-880. doi:  10.31557/APJCP.2020.21.4.867
[36] PHILLIPS C, JEFFREE R, KHASRAW M. Management of breast cancer brain metastases: a practical review[J]. Breast,2017,31:90-98. doi:  10.1016/j.breast.2016.10.006
[37] KIMBUNG S, LOMAN N, HEDENFALK I. Clinical and molecular complexity of breast cancer metastases[J]. Semin Cancer Biol,2015,35:85-95. doi:  10.1016/j.semcancer.2015.08.009
[38] EARLY BREAST CANCER TRIALISTS' COLLABORATIVE GROUP (EBCTCG). Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials[J]. Lancet,2012,379(9814):432-444. doi:  10.1016/S0140-6736(11)61625-5
[39] JIA D, HASSO S M, CHAN J, et al. Transcriptional repression of VEGF by ZNF24: mechanistic studies and vascular consequences in vivo[J]. Blood,2013,121(4):707-715. doi:  10.1182/blood-2012-05-433045
[40] HOU L M, CHEN M S, YANG H W, et al. miR-940 inhibited cell growth and migration in triple-negative breast cancer[J]. Med Sci Monit,2016,22:3666-3672. doi:  10.12659/MSM.897731